Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Enables millions of Indians to monitor their vitals without the need of any additional device
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients
Subscribe To Our Newsletter & Stay Updated
